Image Credit: shortpedia

People in developed nations will have to spend $2,340 for Covid19 drug Remdesivir


Content Team

Gilead Sciences Inc has set the price of Covid19 treatment drug Remdesivir at $2,340 per patient for developed nations. Gilead has agreed to send nearly all of its supply of the drug to United States over the next three months. However, the U.S. drug pricing research group the Institute for Clinical and Economic Review had suggested the price of the drug to be in the range of $2,520 to $2,800, a few days back.